Neogen Net Worth
Neogen Net Worth Breakdown | NEOG |
Neogen Net Worth Analysis
Neogen's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Neogen's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Neogen's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Neogen's net worth analysis. One common approach is to calculate Neogen's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Neogen's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Neogen's net worth. This approach calculates the present value of Neogen's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Neogen's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Neogen's net worth. This involves comparing Neogen's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Neogen's net worth relative to its peers.
Enterprise Value |
|
To determine if Neogen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Neogen's net worth research are outlined below:
| Neogen generated a negative expected return over the last 90 days | |
| The company reported the previous year's revenue of 924.22 M. Net Loss for the year was (9.42 M) with profit before overhead, payroll, taxes, and interest of 409.2 M. | |
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Food Allergen Testing Market Poised for Strong Growth with 7.8 percent CAGR during 2024 to 2034, Fuelled by Rapid Detection Methods Future Market Insights, Inc. |
Neogen Quarterly Good Will |
|
Neogen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Neogen. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Neogen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 25th of July 2024 Next Financial Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View | |
| 25th of July 2024 Next Fiscal Year End | View | |
| 30th of November 2023 Last Quarter Report | View | |
| 31st of May 2023 Last Financial Announcement | View |
Know Neogen's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Neogen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neogen backward and forwards among themselves. Neogen's institutional investor refers to the entity that pools money to purchase Neogen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Champlain Investment Partners, Llc | 2024-09-30 | 7.1 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 5.6 M | T. Rowe Price Investment Management,inc. | 2024-09-30 | 5.6 M | Geode Capital Management, Llc | 2024-06-30 | 5.1 M | King Luther Capital Management Corp | 2024-09-30 | 5.1 M | Northern Trust Corp | 2024-09-30 | 3.6 M | Hhg Plc | 2024-06-30 | 3.6 M | Blair William & Co | 2024-06-30 | 3.5 M | American Capital Management Inc | 2024-09-30 | 3.4 M | Blackrock Inc | 2024-06-30 | 25 M | Vanguard Group Inc | 2024-09-30 | 19.7 M |
Follow Neogen's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.23 B.Market Cap |
|
Project Neogen's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.01 | 0.01 |
When accessing Neogen's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Neogen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Neogen's profitability and make more informed investment decisions.
Evaluate Neogen's management efficiency
The Neogen's current Return On Tangible Assets is estimated to increase to -0.0099. The current Return On Capital Employed is estimated to decrease to 0.01. At this time, Neogen's Other Current Assets are most likely to increase significantly in the upcoming years. The Neogen's current Total Current Assets is estimated to increase to about 618.7 M, while Other Assets are projected to decrease to 0.95. Neogen's management efficiency ratios could be used to measure how well Neogen manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 14.52 | 15.25 | |
| Tangible Book Value Per Share | (2.32) | (2.21) | |
| Enterprise Value Over EBITDA | 19.62 | 16.26 | |
| Price Book Value Ratio | 0.91 | 0.86 | |
| Enterprise Value Multiple | 19.62 | 16.26 | |
| Price Fair Value | 0.91 | 0.86 | |
| Enterprise Value | 3.6 B | 3.8 B |
The management team at Neogen has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Enterprise Value Revenue 4.3851 | Revenue 912.2 M | Quarterly Revenue Growth (0.05) | Revenue Per Share 4.212 | Return On Equity (0.01) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Neogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Neogen Corporate Filings
13A | 14th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
F4 | 5th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 4th of November 2024 Other Reports | ViewVerify | |
8K | 10th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Neogen Earnings per Share Projection vs Actual
Neogen Corporate Management
| John Moylan | Corporate VP | Profile | |
| Bill Waelke | Head Relations | Profile | |
| Julie Mann | VP Officer | Profile | |
| Amy Rocklin | Chief Secretary | Profile | |
| David Naemura | Chief Officer | Profile | |
| Sarah Demey | Administrative Manager | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share (0.11) | Revenue Per Share 4.212 | Quarterly Revenue Growth (0.05) | Return On Assets 0.0085 |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.